Effects of removing lesser omentum on outcomes in ovarian cancer

Impact of Lesser Omentectomy on Oncological and Surgical outcomes outcomes in Advanced Stage Invasive Epithelial Ovarian Carcinoma A Single Arm Prospective Observational Study - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/05/110059

Enrollment

102

Registered

2026-05-05

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C569- Malignant neoplasm of unspecifiedovary

Interventions

Intervention1: Lesser omentectomy during cytoreductive surgery: All eligible patients with advanced epithelial ovarian carcinoma undergoing cytoreductive surgery will undergo systematic lesser omentec

Eligibility

Inclusion criteria

Inclusion criteria: FIGO stage 3 or 4 scheduled for primary or interval cytoreductive surgery. ECOG 0-2 Provided written informed consent

Exclusion criteria

Exclusion criteria: Presence of grossly involved lesser omentum intraoperatively Unresectable disease Recurrent ovarian cancer

Design outcomes

Primary

Measure	Time frame
Detection of occult microscopic metastasis in lesser omentum (histopathological positivity rate)Timepoint: Baseline	—

Secondary

Measure	Time frame
Time to functional recoveryTimepoint: Baseline & 6 months;Quality of Life using EORTC QLQ 30 & OV 28 scoreTimepoint: 6 month;Intra op outcomesTimepoint: Baseline	—

Countries

India

Contacts

Public ContactSHUBHAM MUKHOPADHYAY

AII INDIA INSTITUTE OF MEDICAL SCIENCES , JODHPUR

drdharmapoonia@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026